OVERALL SURVIVAL ASSOCIATED WITH FIRST-LINE PCV OR TEMOZOLOMIDE IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH IDH-MUTANT, 1P/19Q CODELETED, GRADE 3 OLIGODENDROGLIOMA: ANALYSIS FROM THE POLA COHORT

被引：2

作者：

Kacimi, S. E. O. ^{[1
]}

Dehais, C. ^{[2
]}

Carpentier, C. ^{[1
]}

Chinot, O. ^{[3
]}

Bronnimann, C. ^{[4
]}

Vauleon, E. ^{[5
]}

Djelad, A. ^{[6
]}

Moyal, E. C. ^{[7
]}

Campone, M. ^{[8
]}

Ducloie, M. ^{[9
]}

Noel, G. ^{[10
]}

Cuzzubbo, S. ^{[11
]}

Thaillandier, L. ^{[12
,13
]}

Ramirez, C. ^{[14
,15
]}

Colin, C. ^{[16
]}

Appay, R. ^{[16
]}

Tabouret, E. ^{[17
]}

Nichelli, L. ^{[18
]}

Mathon, B. ^{[2
]}

Thomas, A. ^{[19
]}

Tran, S.

Bielle, F. ^{[20
]}

Alentor, A. ^{[2
]}

Labreche, K.

Idbaih, A.

Figarella-Branger, D. ^{[21
]}

Ducray, F. ^{[22
]}

Touat, M. ^{[2
]}

机构：

[1] Hop La Pitie Salpetriere, Inst Cerveau, Paris, France

[2] Hop Univ Pitie Salpetriere Charles Foix, APHP, Serv Neurol Mazarin 2, Paris, France

[3] Aix Marseille Univ, CHU Timone, Assistance Publ Hopi Marseille APHM, Dept Neurooncol, Marseille, France

[4] Univ Hosp Bordeaux, Dept Med Oncol, Bordeaux, France

[5] Ctr Eugene Marquis, Rennes, France

[6] Univ Hosp Lille, Dept Neurosurg, Lille, France

[7] Inst Univ Canc Toulouse Oncopole, Dept Radiat Oncol, Toulouse, France

[8] Inst Cancerol Ouest Pays Loire, Angers, France

[9] Hop Univ Pitie Salpetriere Charles Foix, Neurooncol, Paris, France

[10] Strasbourg Europe Canc Inst ICANS, Dept Radiotherapy, Strasbourg, France

[11] Hosp St Louis, APHP, Dept Neurol, Paris, France

[12] CHU Nancy, Serv Neurol Unite Neuro Oncol, Nancy, France

[13] CHU Nancy, Nancy, France

[14] Lucien Neuwirth Canc Inst, Dept Med Oncol, St Priest En Jarez, France

[15] Univ Hosp St Etienne, North Hosp, Dept Neurol, St Etienne, France

[16] Aix Marseille Univ, CNRS, Inst Neurophysiopathol, INP, Marseille, France

[17] Aix Marseille Univ, CNRS,CHU Timone,APHM,INP, Inst Neurophysiopathol, Serv Neurooncol, Marseille, France

[18] Sorbonne Univ, Grp Hosp Salpetriere, APHP, Serv Neuroradiol, Paris, France

[19] UNICANCER, Dept Radiotherapy, Ctr Paul Strauss, Strasbourg, France

[20] Hop Univ Pitie Salpetriere Charles Foix, APHP, Serv Neuropathol Raymond Escourolle Salpetriere C, Paris, France

[21] Aix Marseille Univ, La Timone Hosp, Dept Pathol & Neuropathol, Paris, France

[22] Civil Hosp Lyon, Pierre Wertheimer Hosp, Dept Neuro Oncol, Bron, France

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

10.1093/neuonc/noad137.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

KS02.5.A

引用

页数：1

共 31 条

[1] Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma.
Kacimi, Salah Eddine O.
Dehais, Caroline
Feuvret, Loic
Chinot, Olivier L.
Carpentier, Catherine
Bronnimann, Charlotte
Vauleon, Elodie
Djelad, Apolline
Moyal, Elizabeth L. Cohen-Jonathan
Langlois, Olivier
Campone, Mario
Ducloie, Mathilde
Noel, Georges
Cuzzubbo, Stefania
Ricard, Damien
Faillot, Thierry
Boelle, Pierre-Yves
Figarella-Branger, Dominique
Ducray, Francois
Touat, Mehdi
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[2] Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma
Kacimi, Salah Eddine O.
Dehais, Caroline
Feuvret, Loic
Chinot, Olivier
Carpentier, Catherine
Bronnimann, Charlotte
Vauleon, Elodie
Djelad, Apolline
Cohen-Jonathan Moyal, Elizabeth
Langlois, Olivier
Campone, Mario
Ducloie, Mathilde
Noel, Georges
Cuzzubbo, Stefania
Taillandier, Luc
Ramirez, Carole
Younan, Nadia
Menei, Philippe
Dhermain, Frederic
Desenclos, Christine
Ghiringhelli, Francois
Bourg, Veronique
Ricard, Damien
Faillot, Thierry
Appay, Romain
Tabouret, Emeline
Nichelli, Lucia
Mathon, Bertrand
Thomas, Alice
Tran, Suzanne
Bielle, Franck
Alentorn, Agusti
Iorgulescu, J. Bryan
Boelle, Pierre-Yves
Labreche, Karim
Hoang-Xuan, Khe
Sanson, Marc
Idbaih, Ahmed
Figarella-Branger, Dominique
Ducray, Francois
Touat, Mehdi
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (03)
[3] Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted
Yasuda, Takayuki
Nitta, Masayuki
Komori, Takashi
Kobayashi, Tatsuya
Masui, Kenta
Maruyama, Takashi
Sawada, Tatsuo
Muragaki, Yoshihiro
Kawamata, Takakazu
NEUROPATHOLOGY, 2018, 38 (01) : 41 - 46
[4] EVALUATING THE SUPER T2-FLAIR MISMATCH SIGN IN OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q CODELETED
Ozono, Iori
Yamasaki, Fumiyuki
Onishi, Shumpei
Yonezawa, Ushio
Taguchi, Akira
Khairunnisa, Novita Ikbar
Horie, Nobutaka
NEURO-ONCOLOGY, 2024, 26
[5] Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients
Juratli, Tareq A.
Lautenschlaeger, Tim
Geiger, Kathrin D.
Pinzer, Thomas
Krause, Mechthild
Schackert, Gabriele
Krex, Dietmar
JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (02) : 197 - 205
[6] Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report
Burgy, Mickael
Chenard, Marie-Pierre
Noel, Georges
Bourahla, Khalil
Schott, Roland
JOURNAL OF MEDICAL CASE REPORTS, 2019, 13 (01)
[7] Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report
Mickaël Burgy
Marie-Pierre Chenard
Georges Noël
Khalil Bourahla
Roland Schott
Journal of Medical Case Reports, 13
[8] Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients
Tareq A. Juratli
Tim Lautenschläger
Kathrin D. Geiger
Thomas Pinzer
Mechthild Krause
Gabriele Schackert
Dietmar Krex
Journal of Neuro-Oncology, 2015, 124 : 197 - 205
[9] Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2
Merchant, Mythili
Raygada, Margarita
Pang, Ying
Quezado, Martha
Raffeld, Mark
Xi, Liqiang
Kim, Jung
Tyagi, Manoj
Abdullaev, Zied
Kim, Olga
Sergi, Zach
Pillai, Tina
Ozer, Byram
Zaghloul, Kareem
Heiss, John D.
Armstrong, Terri S.
Gilbert, Mark R.
Aldape, Kenneth
Wu, Jing
FRONTIERS IN ONCOLOGY, 2022, 12
[10] TRANSCRIPTION FACTOR NETWORKS OF OLIGODENDROGLIOMAS (IDH-MUTANT AND 1p/19q CODELETED) TREATED WITH ADJUVANT RADIOTHERAPY OR OBSERVATION INFORMS PROGNOSIS
So, Jonathan
Moraes, Fabio
Mamatjan, Yasin
Aldape, Kenneth
Zadeh, Gelareh
NEURO-ONCOLOGY, 2018, 20 : 226 - 226

← 1 2 3 4 →